Today’s subject is a “magical” protein molecule that empowers your body to cure itself – or a fraud. Frankly, I don’t know which. And it may be academic because it’s not available now, as far as I know. But I want to report on GcMAF in the interest of giving you a complete picture of what’s happening in the world of alternative treatments.
In healthy people GcMAF molecules are said to be the key “directors” of the immune system. Certain hard-to-cure diseases including cancer neutralize the function of GcMAF. If true, then restoring levels of GcMAF would constitute a powerful therapy.
One hundred eighty scientists have published 73 research papers on GcMAF in the U.S. National Library of Medicine. This is actually not a large number of articles, but it indicates the substance is not unknown.
Unfortunately, it’s hard to say if or when we’ll know more, because the UK’s equivalent of the FDA has shut down production and seized all stocks of the molecule.
Let’s look at the recent research about these critical proteins. . .
The secret to curing cancer:
In 1921, a British doctor discovered that members of a remote native tribe were almost totally cancer-free. But when members of this tribe move away from their native land and change their diet, they get cancer just like anyone else.
It’s all thanks to a food most of us throw away as waste — a food that’s rich in amygdalin — what most of us call Laetrile. Click here now and watch a video presentation about this cancer breakthrough. One cancer expert calls this overlooked food “the key to curing AND preventing cancer” — and you can benefit now — without going to a doctor or buying expensive supplements.
This little throwaway food tastes great. Bill Clinton, of all people, eats a certain amygdalin-rich food all the time, and so can you. Click here now to watch the video!
GcMAF is a human protein your body makes to keep disease in check. All seven billion healthy humans make their own supply of GcMAF (the acronym from “protein derived (Gc) Macrophage Activating Factor.”)
Healthy people produce cancer cells every day. But most of us don’t succumb to the disease because we produce enough of our own GcMAF to attack these alien, defective cells.
GcMAF is said to have at least 11 modes of action in your body that we know of so far. (Some sources say we now know of 20.) Six of those are attacks on cancer, three on the brain, and two on cells. GcMAF tells macrophages to gobble up cancer cells and viruses.
Without GcMAF we would all have died of diseases as children.
Beware the evil enzyme that makes
a mess of your immune system
But as in every novel with a villain, there’s an “evil enzyme” called nagalase that blocks production of GcMAF and causes immunodeficiency.1 This allows viruses and malignant cells like cancer to run roughshod over your immune system.
Nagalase enzymes neutralize your immune system by preventing GcMAF production.
High nagalase levels have been found in the blood of patients with many types of cancer.2,3,4
Nagalase is a matrix-degrading enzyme secreted by cancer cells during the process of tumor invasion.
Levels of nagalase vary by type, size, and stage of the cancer and by degree of invasiveness.5 Some studies show the enzyme’s activity is directly proportional to tumor burden. But increased nagalase activity is not found in the blood of healthy people.6
So if you have cancer or certain other diseases, you can assume you have high nagalase.
How about if you don’t have a disease diagnosis but want to know your nagalase levels? There are a couple labs in Europe that can test for this enzyme. But it can take weeks to get your results.7
Just so you know, a healthy level is below 0.65 nmol/min/mg.
What exactly does GcMAF do?
GcMAF suppresses inflammation and viral infections. In many areas it is also better than antibiotics. As you might guess, GcMAF can tamp down the activity of nagalase.
If your immune system is depressed, GcMAF can help rebuild it.
Researchers also say that GcMAF. . .
- Stops blood flow to tumors
- Activates macrophages – which help destroy cancer cells
- Tells cancer cells to commit suicide (apoptosis)
- Turns cancer cells into healthy ones
- In lab-cultured cells, reduces metastasis
- Boosts energy level in your mitochondria
- Increases your brain’s metabolic activity
Dr. Nabuto Yamamoto, formerly a Professor of Biochemistry at Temple University Medical School in Philadelphia, conducted much of the groundbreaking research on this therapy. Reportedly, several of his articles have been retracted by the journals in which they were published.
I have a low level of trust in the medical and scientific establishment, so I don’t consider this the last word on the subject. As I said at the outset, I’m not in a position to weigh the conflicting claims.
Dr. Yamamoto treated 16 metastatic breast cancer patients with a single injection of GcMAF per week for 22 weeks. It cleared the cancer, and patients were still well four years later.
In another study, all 16 metastatic prostate patients became cancer free and remained so even seven years later.
Finally, all eight metastatic colorectal cancer patients were free of cancer after 48 weeks and were still cancer-free seven years later, confirmed by CT scans.
It sounds hard to believe, but he reportedly achieved a 100 percent remission rate in metastatic cancer patients. Normally the survival chances of a metatstatic cancer patient are slim to none if they rely on conventional treatments.
Because of its immune-building properties, GcMAF’s advocates say it can help a large number of chronic diseases, including chronic cases of acne, cirrhosis of the liver, herpes, kidney disease, autism, depression, colitis, Crohn’s, fibromyalgia, hepatitis, chronic fatigue syndrome, and osteoporosis.
Researchers also say it can halt deterioration in those with Parkinson’s, MS, dementia, and ALS, and help patients with lupus, arthritis, and various allergies.
The GcMAF “super-molecule” as a replacement therapy
If your body doesn’t produce enough GcMAF, you may be able to get it as a replacement therapy, but it won’t be easy.
And don’t expect to hear about it from your doctor.
The most likely reason the treatment has been suppressed is the giant pharmaceutical companies and their power brokers in Washington – and elsewhere. It’s not just U.S. regulators who bar your access to this therapy.
In February, 2015, UK regulators raided the facilities of ImmunoBiotech, GcMAF’s maker, terrorizing employees, and seizing 10,000 vials of the product. Cancer patients on Guernsey, (one of Britain’s Channel Islands where the plant is located) who were taking the supplement were alarmed and feared their cancer would return without it.
Apparently, hundreds of anecdotal reports of reversals of cancer and autism pose a threat to those companies that reap billions from conventional therapies.
Restarts your immune system within minutes
When supplemental GcMAF is given, it is said to restart the immune system within minutes, spurring attacks on disease. Within three weeks your immune system is rebuilt to above normal strength.
According to its advocates, it’s important to continue the GcMAF until your nagalase levels drop below 0.65 (healthy normal levels), otherwise your cancer may return.
The beauty of this treatment, of course, is that it’s a potent immune enhancer. And since the healthy body abounds in natural GcMAF, practitioners say the therapy has no side effects.
There are a couple things that go hand-in-hand with the treatment… a special blend of probiotics (similar to human colostrum), unsaturated fatty acids (specifically oleic acid) and very high doses of vitamin D3.
These are the nutrients your body naturally uses to create GcMAF proteins. If you’re deficient in them, you’ll have a hard time producing GcMAF. And it follows that you’ll be hindered in cleaning up cancer cells, attacking tumors, eliminating viruses, and staying healthy.7
Many drugs, including LDN (low dose naltrexone) interfere with the action of GcMAF. LDN is itself an effective alternative cancer treatment but it doesn’t go well with this one.
You used to be able to get GcMAF treatment in European clinics, but they appear to have been shut down after the UK raid. There may be new clinics in Europe at undisclosed locations. We have no confirmation of that.
When we first wrote about GcMAF a little more than a year ago (Issue #522), we were hoping to interview doctors at a clinic in the Bahamas that offered GcMAF. They refused to speak with us, possibly because they don’t want publicity or fear we are government agents.
Let’s hope this suppressed but promising treatment turns out to be as wonderful as its adherents claim — and that regulators will actually allow us to have it.